Claims for Patent: 4,849,508

Summary for Patent: 4,849,508

Title:	Pasteurization of immunoglobulin solutions
Abstract:	Pasteurization of immunoglobulin solutions to inactivate viruses without significantly altering the IgG molecules or their physiological activities is obtained with minimal aggregation in the absence of any stabilizer by heating this solution to mildly-elevated temperatures at low ionic strength and mildly acid pH values.
Inventor(s):	Magnin; Anthony A. (Willowdale, CA), Wah; Po-Shing (Willowdale, CA), Dennis; Paul (Mississauga, CA)
Assignee:	Connaught Laboratories Limited (Willowdale, CA)
Application Number:	07/124,622
Patent Claims:	1. A method of pasteurization of an aqueous solution of an immunglobulin containing less than about 5 wt. % of protein, which comprises heating said solution, in the absence of additives, stabilizers or excipients, at a temperature of about 35.degree. C. to about 75.degree. C. at a pH of about 3.5 to about 6.5 at an ionic strength less than that of an 0.05 mM aqueous solution of sodium chloride for a time sufficient of effect pasteurization of said solution, whereby viruses present in said aqueous solution are inactivated while retaining the biological activity of the immunoglobulin and producing less than about 5% aggregation of the immunoglobulin. 2. The method of claim 1 wherein said immunoglobulin solution has a protein concentration less than about 2 wt. %. 3. The method of claim 1 wherein said temperature is about 50.degree. to about 60.degree. C. 4. The method of claim 1 wherein said solution has a pH of about 4 to about 6. 5. The method of claim 1 wherein said immunoglobulin solution has an ionic strength less than that of aqueous 0.05 mM NaCl solution, has a protein concentration less than about 2 wt. % and has a pH of about 4 to 6. 6. The method of claim 5 wherein said temperature is about 50.degree. to about 60.degree. C. 7. The method of claim 6 wherein said solution contains less than 0.5% w/v of ethanol. 8. The method of claim 1 wherein said aqueous solution of an immunoglobulin is an aqueous solution of gammaglobulin. 9. The method of claim 1 wherein said aqueous solution of an immunoglobulin is an intravenous immunoglobulin. 10. The method of claim 1 wherein said aqueous solution of an immunoglobulin is a hyperimmune globulin. 11. The method of claim 10 wherein said hyperimmune globulin is Rho(D) immune globulin. 12. The method of claim 10 wherein said hyperimmune globulin is hepatitis B immune globulin. 13. The method of claim 1 wherein said aqueous solution of an immunoglobulin is a monoclonal antibody of the IgG class. 14. The method of claim 1 wherein said aqueous solution of an immunoglobulin is a monoclonal antibody of the IgG1 subclass. 15. The method of claim 1 wherein said aqueous solution of an immunoglobulin is a human myeloma protein of the IgG class. 16. The method of claim 1 wherein said aqueous solution of an immunoglobulin is a human myeloma protein of the IgG1 subclass.

Details for Patent 4,849,508

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Kamada Ltd.	WINRHO SD, WINRHO SDF LIQUID, WINRHO SDF LYOPHILIZED	rho(d) immune globulin intravenous (human)	For Injection	103649	April 02, 1996		2006-11-25
Kamada Ltd.	WINRHO SD, WINRHO SDF LIQUID, WINRHO SDF LYOPHILIZED	rho(d) immune globulin intravenous (human)	Injection	103649	March 31, 2005		2006-11-25
Kamada Ltd.	WINRHO SD, WINRHO SDF LIQUID, WINRHO SDF LYOPHILIZED	rho(d) immune globulin intravenous (human)	Injection	103649	December 18, 2015		2006-11-25